NIMG-11. IDENTIFYING EARLY INDICATORS OF IMMUNOTHERAPEUTIC RESPONSE: CAR T-CELL THERAPY

The current guideline to assess radiological changes in response to immunotherapy, iRANO, faces critical challenges in the determination of progressive disease during the first 6 months from the start of therapy. In patients with recurrent glioblastoma (GBM), immunotherapy induces an inflammatory re...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: De Leon, Gustavo, Johnston, Sandra, Hawkins-Daarud, Andrea, Singleton, Kyle, Jackson, Pamela, Rickertsen, Cassandra, Bayless, Spencer, Porter, Alyx, Mrugala, Maciej, Bendok, Bernard, Rodriguez, Analiz, Badie, Behnam, Sahoo, Prativa, Rockne, Russell C, Brown, Christine, Swanson, Kristin R
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2017
Matèries:
Abstracts
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5693082/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.590
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars